Status: Not yet recruiting
Zotatifin And EIF4A Platinum Helix Inhibition In Resistant AdvancedTNBC
To find the optimal (best) recommended dose of zotatifin and carboplatin to treat patients with metastatic or recurrent TNBC.
Participants needed: 24
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Sep 8, 2026Locations: 1
Eligibility criteria
Participants must have histologically confirmed malignancy that is metastatic or... [+20]
Participants who have not recovered from adverse events due to prior anti-cancer... [+18]